Catherine Reenaers

Summary

Country: Belgium

Publications

  1. pmc Impact of medical therapies on inflammatory bowel disease complication rate
    Catherine Reenaers
    Department of Gastroenterology, CHU Sart Tilman, University of Liege, Liege, Belgium
    World J Gastroenterol 18:3823-7. 2012
  2. doi Necessity of phenotypic classification of inflammatory bowel disease
    Edouard Louis
    Department of Gastroenterology, University hospital of Liége CHU, Liege University, Liege, Belgium
    Best Pract Res Clin Gastroenterol 25:S2-7. 2011
  3. doi Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring
    José Manuel Benitez
    Department of Gastroenterology, University Hospital CHU of Liege, Liege, Belgium
    Gut 62:1806-16. 2013
  4. pmc Do clinical factors help to predict disease course in inflammatory bowel disease?
    Edouard Louis
    Department of Gastroenterology, CHU Liege, Liege University, 4000 Liege, Belgium
    World J Gastroenterol 16:2600-3. 2010
  5. doi Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease
    Catherine Reenaers
    Department of Gastroenterology, University of Liege, CHU Sart Tilman, Liege, Belgium
    Scand J Gastroenterol 43:1334-45. 2008
  6. ncbi Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level
    Marie Armelle Denis
    Department of Gastroenterology, Clinique St Joseph, Liege, Belgium
    Inflamm Bowel Dis 13:1100-5. 2007
  7. pmc Current directions of biologic therapies in inflammatory bowel disease
    Catherine Reenaers
    Gastroenterology, CHU Sart Tilman, 4000 Liege, Belgium
    Therap Adv Gastroenterol 3:99-106. 2010
  8. pmc Tailoring the treatment to the individual in Crohn's disease
    Edouard Louis
    Department of Gastroenterology, CHU of Liége and GIGA Research, University of Liege, Belgium
    Therap Adv Gastroenterol 2:239-44. 2009
  9. pmc Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations
    Edouard Louis
    Department of Gastroenterology, University Hospital CHU of Liege, Liege, Belgium
    J Crohns Colitis 9:685-91. 2015
  10. doi Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease
    Yukihide Momozawa
    Unit of Animal Genomics, Groupe Interdisciplinaire de Génoprotéomique Appliquée GIGA R and Faculty of Veterinary Medicine, University of Liège B34, Liege, Belgium
    Nat Genet 43:43-7. 2011

Collaborators

Detail Information

Publications10

  1. pmc Impact of medical therapies on inflammatory bowel disease complication rate
    Catherine Reenaers
    Department of Gastroenterology, CHU Sart Tilman, University of Liege, Liege, Belgium
    World J Gastroenterol 18:3823-7. 2012
    ..Treatment strategy in inflammatory bowel diseases should thus be tailored according to the risk that each patient could develop disabling disease...
  2. doi Necessity of phenotypic classification of inflammatory bowel disease
    Edouard Louis
    Department of Gastroenterology, University hospital of Liége CHU, Liege University, Liege, Belgium
    Best Pract Res Clin Gastroenterol 25:S2-7. 2011
    ..This subclassification also has a very significant clinical relevance since extensive colitis has been associated with and increased risk of colon cancer, colectomy and even in some studies, mortality...
  3. doi Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring
    José Manuel Benitez
    Department of Gastroenterology, University Hospital CHU of Liege, Liege, Belgium
    Gut 62:1806-16. 2013
    ..In particular, with the use of appropriate threshold values, they could determine the need for endoscopic or medical imaging procedures to confirm the disease activity state. ..
  4. pmc Do clinical factors help to predict disease course in inflammatory bowel disease?
    Edouard Louis
    Department of Gastroenterology, CHU Liege, Liege University, 4000 Liege, Belgium
    World J Gastroenterol 16:2600-3. 2010
    ..Besides these important factors, others may predispose to some specific disease evolution and complications, and are also reviewed in the present paper...
  5. doi Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease
    Catherine Reenaers
    Department of Gastroenterology, University of Liege, CHU Sart Tilman, Liege, Belgium
    Scand J Gastroenterol 43:1334-45. 2008
    ..The aim of this work was to study TRAIL expression and the effects on intestinal fibroblasts (IFs) in CD...
  6. ncbi Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level
    Marie Armelle Denis
    Department of Gastroenterology, Clinique St Joseph, Liege, Belgium
    Inflamm Bowel Dis 13:1100-5. 2007
    ..The aim of our work was to assess intestinal and colonic lesions in such patients and to look for biological markers potentially associated with endoscopic activity of the disease...
  7. pmc Current directions of biologic therapies in inflammatory bowel disease
    Catherine Reenaers
    Gastroenterology, CHU Sart Tilman, 4000 Liege, Belgium
    Therap Adv Gastroenterol 3:99-106. 2010
    ..Monoclonal antibodies targeting other cytokines are also under development. For example, ustekinumab (CNTO 1275) inhibits interleukins 12 and 23. It is associated with a good clinical response in CD...
  8. pmc Tailoring the treatment to the individual in Crohn's disease
    Edouard Louis
    Department of Gastroenterology, CHU of Liége and GIGA Research, University of Liege, Belgium
    Therap Adv Gastroenterol 2:239-44. 2009
    ....
  9. pmc Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations
    Edouard Louis
    Department of Gastroenterology, University Hospital CHU of Liege, Liege, Belgium
    J Crohns Colitis 9:685-91. 2015
    ..A series of pragmatic recommendations relating to IBD unit optimisation have been developed through discussion among a large panel of international experts...
  10. doi Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease
    Yukihide Momozawa
    Unit of Animal Genomics, Groupe Interdisciplinaire de Génoprotéomique Appliquée GIGA R and Faculty of Veterinary Medicine, University of Liège B34, Liege, Belgium
    Nat Genet 43:43-7. 2011
    ....